APA (7th ed.) Citation

E, W., L, S., F, M., D, G., G, C., T, G., . . . P, F. (2022). Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 63(4), 549. https://doi.org/10.2967/jnumed.120.245357

Chicago Style (17th ed.) Citation

E, Woff, et al. "Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 63, no. 4 (2022): 549. https://doi.org/10.2967/jnumed.120.245357.

MLA (9th ed.) Citation

E, Woff, et al. "Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 63, no. 4, 2022, p. 549, https://doi.org/10.2967/jnumed.120.245357.